CANKADO is introducing a new technology in digital healthcare applications on Oncology. The technology assists a cancer patient and an oncologist in the phase of cancer treatment. This innovation works on the basis of patient-reported outcome data allowing an efficient patient-physician interface.
At one place know the best information on various cancer drugs and common symptoms associated.
CANKADO’s PRO-react Onco helps efficient patient physician communication in the treatment phase.
© 2020 Cancer.Cankado. All rights Reserved
CANKADO is approved as an active Class I medical device within the European Union (registration number DE/CA59/11976/2017) and is compliant with the FDA classification for Mobile Medical Devices (2015) Appendix B.